What Researchers Did
Researchers conducted a narrative review to evaluate current non-steroid treatment options for idiopathic sudden sensorineural hearing loss (ISSNHL).
What They Found
The review highlighted that systematic steroids are commonly used as first-line treatment for ISSNHL due to their anti-inflammatory effects. However, significant controversy persists regarding the efficacy of steroids and alternative non-steroid treatments like hyperbaric oxygen therapy, N-acetylcysteine, and defibrinogenation therapy.
What This Means for Canadian Patients
Canadian patients with sudden sensorineural hearing loss may benefit from ongoing research into the most effective non-steroid treatments. This review helps inform healthcare providers about the current evidence and controversies surrounding various treatment options, potentially leading to more refined care strategies.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a narrative review, this study may be subject to selection bias in the included literature and does not provide a systematic analysis of evidence.